Literature DB >> 1929786

Emerging patterns of cocaine use and the epidemic of cocaine overdose deaths in Dade County, Florida.

L G Escobedo1, A J Ruttenber, M M Agocs, R F Anda, C V Wetli.   

Abstract

With the increasing use of cocaine in the United States, cocaine overdose deaths are being reported with increasing frequency. To describe patterns of cocaine use involved in cocaine overdose deaths, we reviewed the postmortem records from the Metropolitan Dade County Medical Examiner Department, Miami, Fla. We identified 239 cocaine overdose deaths from 1971 through 1987. During this period, the incidence of cocaine overdose deaths increased 20-fold, with the largest proportional increases occurring among persons aged older than 24 years, white persons, and men. The percentage of deaths that involved use of cocaine by nonparenteral routes, as well as newer and unknown preparations of cocaine (such as "crack" and "free-base" cocaine), increased. For example, the percentage of deaths that involved use of crack or free-base cocaine increased from 8% in 1981 to 20% in 1987. Persons who died after smoking crack or free-base cocaine had lower blood cocaine levels at autopsy (median level, 0.3 mg/L) than persons who died as a result of using cocaine hydrochloride (median level, 3.7 mg/L). Patterns of cocaine use involved in the epidemic of cocaine overdose deaths are changing. The data suggest that the newer preparations of cocaine, such as crack or free-base cocaine are playing an increasingly important role in this epidemic and that these preparations may be more toxic than cocaine hydrochloride.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1929786

Source DB:  PubMed          Journal:  Arch Pathol Lab Med        ISSN: 0003-9985            Impact factor:   5.534


  9 in total

Review 1.  Neuropsychiatric effects of cocaine use disorders.

Authors:  Charles U Nnadi; Olubansile A Mimiko; Henry L McCurtis; Jean Lud Cadet
Journal:  J Natl Med Assoc       Date:  2005-11       Impact factor: 1.798

2.  Cocaine abusers have an overexpression of alpha-synuclein in dopamine neurons.

Authors:  Deborah C Mash; Qinjie Ouyang; John Pablo; Margaret Basile; Sari Izenwasser; Abraham Lieberman; Richard J Perrin
Journal:  J Neurosci       Date:  2003-04-01       Impact factor: 6.167

3.  Opiates or cocaine: mortality from acute reactions in six major Spanish cities. State Information System on Drug Abuse (SEIT) Working Group.

Authors:  J Sánchez; B Rodríguez; L de la Fuente; G Barrio; J Vicente; J Roca; L Royuela
Journal:  J Epidemiol Community Health       Date:  1995-02       Impact factor: 3.710

4.  Adaptive increase in D3 dopamine receptors in the brain reward circuits of human cocaine fatalities.

Authors:  J K Staley; D C Mash
Journal:  J Neurosci       Date:  1996-10-01       Impact factor: 6.167

5.  Coronary Heart Disease (CHD) Risk Factors and Metabolic Syndrome in HIV-Positive Drug Users in Miami.

Authors:  Marianna K Baum; Carlin Rafie; Shenghan Lai; Lihua Xue; Sabrina Sales; J Bryan Page; Ronald Berkman; Linden Karas; Adriana Campa
Journal:  Am J Infect Dis       Date:  2006

6.  Cocaine inhibits cromakalim-activated K+ currents in follicle-enclosed Xenopus oocytes.

Authors:  Murat Oz; Irina Zakharova; Meral Dinc; Toni Shippenberg
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2003-12-03       Impact factor: 3.000

7.  Effect of cocaine on the contracture response to 1% halothane in patients undergoing diagnostic muscle biopsy for malignant hyperthermia.

Authors:  N Sato; J M Brum; H Mitsumoto; G E DeBoer
Journal:  Can J Anaesth       Date:  1995-02       Impact factor: 5.063

8.  The impact of drug-related deaths on mortality among young adults in Madrid.

Authors:  L de la Fuente; G Barrio; J Vicente; M J Bravo; J Santacreu
Journal:  Am J Public Health       Date:  1995-01       Impact factor: 9.308

Review 9.  The Sigma-1 Receptor: When Adaptive Regulation of Cell Electrical Activity Contributes to Stimulant Addiction and Cancer.

Authors:  Olivier Soriani; Saïd Kourrich
Journal:  Front Neurosci       Date:  2019-11-12       Impact factor: 4.677

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.